Postpartum Hormonal Contraceptives Tied to Higher Depression Risk
By Lori Solomon HealthDay Reporter
THURSDAY, April 3, 2025 -- Use of hormonal contraceptives postpartum is associated with an increased risk for developing postpartum depression, according to a study published online March 31 in JAMA Network Open.
Søren Vinther Larsen, Ph.D., from the Copenhagen University Hospital-Rigshospitalet in Denmark, and colleagues conducted a population-based cohort study based on nationwide Danish register data in primiparous women who gave birth from Jan. 1, 1997, through Dec. 31, 2022, to examine whether hormonal contraceptive initiation postpartum is associated with the development of depression within 12 months. The analysis included 610,038 first-time mothers.
The researchers found that 40.7 percent of first-time mothers initiated hormonal contraceptives within 12 months postpartum. There was an association between hormonal contraceptive initiation and subsequent depression (adjusted hazard ratio, 1.49) compared with no use, resulting in an increase in the 12-month absolute risk from 1.36 to 1.54 percent. For combined oral contraceptives, combined nonoral contraceptives, and progestogen-only nonoral contraceptives, risk was higher (adjusted hazard ratios, 1.72, 1.97, and 1.40, respectively). Use of progestogen-only pills was associated with short-term lower risk, but increased risk late postpartum. The earlier postpartum combined oral contraceptives were initiated, the higher the associated rate ratio of depression.
"These findings raise the issue of whether the incidence of depression postpartum may be inflated by routine hormonal contraceptive initiation, which is important information to convey at postpartum contraceptive counseling," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Late-Life Mood Disorders May Indicate Predisposition to Dementia
MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9...
Addictive Screen Use Tied to Suicidal Behaviors in Early Adolescence
FRIDAY, June 27, 2025 -- Both high and increasing addictive screen use trajectories are associated with suicidal behaviors and worse mental health in early adolescence, according...
Desogestrel for More Than Five Years May Up Risk of Intracranial Meningioma
WEDNESDAY, June 25, 2025 -- Women who have used the oral contraceptive desogestrel (75 µg) for more than five continuous years have a small increased risk of intracranial...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.